Abstract
Metabolic syndrome is a complex disorder that comprises several other complex disorders, including obesity, hypertension, dyslipidemia, and diabetes. There are several rat models that encompass component features of MetS. Some models are inbred strains selected for one or more traits underlying MetS; others are population models with genetic risk for MetS traits, are induced by environmental stressors such as diet, are spontaneous monogenic mutant models, or are congenic strains derived from a combination of these models. Together they can be studied to identify the genetic and physiological underpinnings of MetS to identify candidate genes or mechanisms for study in human MetS subjects.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Reaven GM (1988) Banting lecture 1988. Role of insulin resistance in human disease. Diabetes 37(12):1595–1607
Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA et al (2009) Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation 120(16):1640–1645. https://doi.org/10.1161/CIRCULATIONAHA.109.192644
Saklayen MG (2018) The global epidemic of the metabolic syndrome. Curr Hypertens Rep 20(2):12. https://doi.org/10.1007/s11906-018-0812-z
Nolan PB, Carrick-Ranson G, Stinear JW, Reading SA, Dalleck LC (2017) Prevalence of metabolic syndrome and metabolic syndrome components in young adults: a pooled analysis. Prev Med Rep 7:211–215. https://doi.org/10.1016/j.pmedr.2017.07.004
Lin HF, Boden-Albala B, Juo SH, Park N, Rundek T, Sacco RL (2005) Heritabilities of the metabolic syndrome and its components in the Northern Manhattan Family Study. Diabetologia 48(10):2006–2012. https://doi.org/10.1007/s00125-005-1892-2
Henneman P, Aulchenko YS, Frants RR, van Dijk KW, Oostra BA, van Duijn CM (2008) Prevalence and heritability of the metabolic syndrome and its individual components in a Dutch isolate: the Erasmus Rucphen Family study. J Med Genet 45(9):572–577. https://doi.org/10.1136/jmg.2008.058388
Khan RJ, Gebreab SY, Sims M, Riestra P, Xu R, Davis SK (2015) Prevalence, associated factors and heritabilities of metabolic syndrome and its individual components in African Americans: the Jackson Heart Study. BMJ Open 5(10):e008675. https://doi.org/10.1136/bmjopen-2015-008675
van Dongen J, Willemsen G, Chen WM, de Geus EJ, Boomsma DI (2013) Heritability of metabolic syndrome traits in a large population-based sample. J Lipid Res 54(10):2914–2923. https://doi.org/10.1194/jlr.P041673
Hayman GT, Laulederkind SJ, Smith JR, Wang SJ, Petri V, Nigam R et al (2016) The disease portals, disease-gene annotation and the rgd disease ontology at the rat genome database. Database 2016:baw034. https://doi.org/10.1093/database/baw034
Oschry Y, Eisenberg S (1982) Rat plasma lipoproteins: re-evaluation of a lipoprotein system in an animal devoid of cholesteryl ester transfer activity. J Lipid Res 23(8):1099–1106
Bergen WG, Mersmann HJ (2005) Comparative aspects of lipid metabolism: impact on contemporary research and use of animal models. J Nutr 135(11):2499–2502. https://doi.org/10.1093/jn/135.11.2499
Yin W, Carballo-Jane E, McLaren DG, Mendoza VH, Gagen K, Geoghagen NS et al (2012) Plasma lipid profiling across species for the identification of optimal animal models of human dyslipidemia. J Lipid Res 53(1):51–65. https://doi.org/10.1194/jlr.M019927
Tryon RC (1940) Genetic differences in maze-learning ability in rats. In: Thirty-ninth yearbook of the National Society for the Study of Education. Intelligence: its nature and nurture, part 1. Comparative and critical exposition. Public School Publishing Co., Bloomington, IN, pp 111–119
Eriksson K (1968) Genetic selection for voluntary alcohol consumption in the albino rat. Science 159(3816):739–741. https://doi.org/10.1126/science.159.3816.739
Rapp JP (2000) Genetic analysis of inherited hypertension in the rat. Physiol Rev 80(1):135–172
Goto Y, Kakizaki M, Masaki N (1976) Production of spontaneous diabetic rats by repetition of selective breeding. Tohoku J Exp Med 119(1):85–90
Dupont J, Dupont JC, Froment A, Milon H, Vincent M (1973) Selection of three strains of rats with spontaneously different levels of blood pressure. Biomedicine 19(1):36–41
Su DF, Cerutti C, Barres C, Vincent M, Sassard J (1986) Blood pressure and baroreflex sensitivity in conscious hypertensive rats of Lyon strain. Am J Phys 251(6 Pt 2):H1111–H1117
Sassard J, Vincent M, Orea V, Privat P, Bataillard A (1997) Genetics of blood pressure and associated phenotypes in the Lyon rat. Clin Exp Hypertens 19(5–6):567–575
Florin M, Lo M, Liu KL, Sassard J (2001) Salt sensitivity in genetically hypertensive rats of the Lyon strain. Kidney Int 59(5):1865–1872
Sassolas A, Vincent M, Benzoni D, Sassard J (1981) Plasma lipids in genetically hypertensive rats of the Lyon strain. J Cardiovasc Pharmacol 3(5):1008–1014
Vincent M, Boussairi EH, Cartier R, Lo M, Sassolas A, Cerutti C et al (1993) High blood pressure and metabolic disorders are associated in the Lyon hypertensive rat. J Hypertens 11(11):1179–1185
Boulanger M, Duhault J, Broux O, Bataillard A, Sassard J (1997) Lack of insulin resistance in the Lyon hypertensive rat. Fundam Clin Pharmacol 11(6):546–549
Vincent M, Cartier R, Privat P, Benzoni D, Samani NJ, Sassard J (1996) Major cardiovascular risk factors in Lyon hypertensive rats. A correlation analysis in a segregating population. J Hypertens 14(4):469-474
Dubay C, Vincent M, Samani NJ, Hilbert P, Kaiser MA, Beressi J-P et al (1993) Genetic determinants of diastolic and pulse pressure map to different loci in Lyon hypertensive rats. Nat Genet 3(4):354–357
Bilusic M, Bataillard A, Tschannen MR, Gao L, Barreto NE, Vincent M et al (2004) Mapping the genetic determinants of hypertension, metabolic diseases, and related phenotypes in the lyon hypertensive rat. Hypertension 44(5):695–701. https://doi.org/10.1161/01.HYP.0000144542.57306.5e
Ma MCJ, Pettus JM, Jakoubek JA, Traxler MG, Clark KC, Mennie AK et al (2017) Contribution of independent and pleiotropic genetic effects in the metabolic syndrome in a hypertensive rat. PLoS One 12(8):e0182650. https://doi.org/10.1371/journal.pone.0182650
Wang J, Ma MC, Mennie AK, Pettus JM, Xu Y, Lin L et al (2015) Systems biology with high-throughput sequencing reveals genetic mechanisms underlying the metabolic syndrome in the Lyon hypertensive rat. Circ Cardiovasc Genet 8(2):316–326. https://doi.org/10.1161/CIRCGENETICS.114.000520
Kloting N, Bluher M, Kloting I (2006) The polygenetically inherited metabolic syndrome of WOKW rats is associated with insulin resistance and altered gene expression in adipose tissue. Diabetes Metab Res Rev 22(2):146–154. https://doi.org/10.1002/dmrr.582
van den Brandt J, Kovacs P, Kloting I (2002) Metabolic syndrome and aging in Wistar Ottawa Karlsburg W rats. Int J Obes Relat Metab Disord 26(4):573–576
van den Brandt J, Kovacs P, Kloting I (2000) Features of the metabolic syndrome in the spontaneously hypertriglyceridemic Wistar Ottawa Karlsburg W (RT1u Haplotype) rat. Metabolism 49(9):1140–1144. https://doi.org/10.1053/meta.2000.8610
Kovacs P, Voigt B, Berg S, Vogt L, Kloting I (1997) WOK.1W rats. A potential animal model of the insulin resistance syndrome. Ann N Y Acad Sci 827:94–99
Yagi K, Kim S, Wanibuchi H, Yamashita T, Yamamura Y, Iwao H (1997) Characteristics of diabetes, blood pressure, and cardiac and renal complications in Otsuka Long-Evans Tokushima Fatty rats. Hypertension 29(3):728–735
Kawano K, Hirashima T, Mori S, Saitoh Y, Kurosumi M, Natori T (1992) Spontaneous long-term hyperglycemic rat with diabetic complications. Otsuka Long-Evans Tokushima Fatty (OLETF) strain. Diabetes 41(11):1422–1428
Weingarten A, Turchetti L, Krohn K, Kloting I, Kern M, Kovacs P et al (2016) Novel genes on rat chromosome 10 are linked to body fat mass, preadipocyte number and adipocyte size. Int J Obes 40(12):1832–1840. https://doi.org/10.1038/ijo.2016.127
Baguhl R, Wilke B, Kloting N, Kloting I (2009) Genes on rat chromosomes 3, 5, 10, and 16 are linked with facets of metabolic syndrome. Obesity (Silver Spring) 17(6):1215–1219. https://doi.org/10.1038/oby.2008.658
Kloting N, Wilke B, Kloting I (2007) Triplet repeat in the Repin1 3′-untranslated region on rat chromosome 4 correlates with facets of the metabolic syndrome. Diabetes Metab Res Rev 23(5):406–410. https://doi.org/10.1002/dmrr.713
Kose H, Moralejo DH, Ogino T, Mizuno A, Yamada T, Matsumoto K (2002) Examination of OLETF-derived non-insulin-dependent diabetes mellitus QTL by construction of a series of congenic rats. Mamm Genome 13(10):558–562. https://doi.org/10.1007/s00335-002-2199-y
Muramatsu Y, Yamada T, Taniguchi Y, Ogino T, Kose H, Matsumoto K et al (2005) Pnlip encoding pancreatic lipase is possible candidate for obesity QTL in the OLETF rat. Biochem Biophys Res Commun 331(4):1270–1276. https://doi.org/10.1016/j.bbrc.2005.04.040
Watanabe TK, Suzuki M, Yamasaki Y, Okuno S, Hishigaki H, Ono T et al (2005) Mutated G-protein-coupled receptor GPR10 is responsible for the hyperphagia/dyslipidaemia/obesity locus of Dmo1 in the OLETF rat. Clin Exp Pharmacol Physiol 32(5–6):355–366. https://doi.org/10.1111/j.1440-1681.2005.04196.x
Moran TH (2008) Unraveling the obesity of OLETF rats. Physiol Behav 94(1):71–78. https://doi.org/10.1016/j.physbeh.2007.11.035
Swales JD (1994) Textbook of hypertension. Blackwell Scientific Publications, Oxford
de Jong W (1984) Experimental and genetic models of hypertension. In: Birkenhager WH, Reid JL (eds) Handbook of hypertension, vol 4. Elsevier, Amsterdam
Coan PM, Hummel O, Garcia Diaz A, Barrier M, Alfazema N, Norsworthy PJ et al (2017) Genetic, physiological and comparative genomic studies of hypertension and insulin resistance in the spontaneously hypertensive rat. Dis Model Mech 10(3):297–306. https://doi.org/10.1242/dmm.026716
Pravenec M, Kren V, Landa V, Mlejnek P, Musilova A, Silhavy J et al (2014) Recent progress in the genetics of spontaneously hypertensive rats. Physiol Res 63(Suppl 1):S1–S8
Tofovic SP, Jackson EK (2003) Rat models of the metabolic syndrome. Methods Mol Med 86:29–46. https://doi.org/10.1385/1-59259-392-5:29
Aitman TJ, Gotoda T, Evans AL, Imrie H, Heath KE, Trembling PM et al (1997) Quantitative trait loci for cellular defects in glucose and fatty acid metabolism in hypertensive rats. Nat Genet 16(2):197–201. https://doi.org/10.1038/ng0697-197
Doris PA (2017) Genetics of hypertension: an assessment of progress in the spontaneously hypertensive rat. Physiol Genomics 49(11):601–617. https://doi.org/10.1152/physiolgenomics.00065.2017
Pravenec M, Kurtz TW (2010) Recent advances in genetics of the spontaneously hypertensive rat. Curr Hypertens Rep 12(1):5–9. https://doi.org/10.1007/s11906-009-0083-9
Aitman TJ, Glazier AM, Wallace CA, Cooper LD, Norsworthy PJ, Wahid FN et al (1999) Identification of Cd36 (Fat) as an insulin-resistance gene causing defective fatty acid and glucose metabolism in hypertensive rats. Nat Genet 21(1):76–83
Pravenec M, Kozich V, Krijt J, Sokolova J, Zidek V, Landa V et al (2016) Genetic variation in renal expression of folate receptor 1 (Folr1) gene predisposes spontaneously hypertensive rats to metabolic syndrome. Hypertension 67(2):335–341. https://doi.org/10.1161/HYPERTENSIONAHA.115.06158
Pravenec M, Zidek V, Landa V, Mlejnek P, Silhavy J, Simakova M et al (2017) Mutant Wars2 gene in spontaneously hypertensive rats impairs brown adipose tissue function and predisposes to visceral obesity. Physiol Res 66(6):917–924
Zicha J, Pechanova O, Cacanyiova S, Cebova M, Kristek F, Torok J (2006) Hereditary hypertriglyceridemic rat: a suitable model of cardiovascular disease and metabolic syndrome? Physiol Res 55(Suppl 1):S49–S63
Klimes I, Vrana A, Kunes J, Sebokova E, Dobesova Z, Stolba P et al (1995) Hereditary hypertriglyceridemic rat: a new animal model of metabolic alterations in hypertension. Blood Press 4(3):137–142
Stolba P, Dobesova Z, Husek P, Opltova H, Zicha J, Vrana A et al (1992) The hypertriglyceridemic rat as a genetic model of hypertension and diabetes. Life Sci 51(10):733–740
Ueno T, Tremblay J, Kunes J, Zicha J, Dobesova Z, Pausova Z et al (2004) Rat model of familial combined hyperlipidemia as a result of comparative mapping. Physiol Genomics 17(1):38–47
Sedova L, Kazdova L, Seda O, Krenova D, Kren V (2000) Rat inbred PD/cub strain as a model of dyslipidemia and insulin resistance. Folia Biol (Praha) 46(3):99–106
Seda O, Liska F, Krenova D, Kazdova L, Sedova L, Zima T et al (2005) Dynamic genetic architecture of metabolic syndrome attributes in the rat. Physiol Genomics 21(2):243–252. https://doi.org/10.1152/physiolgenomics.00230.2004
Sasase T, Ohta T, Masuyama T, Yokoi N, Kakehashi A, Shinohara M (2013) The spontaneously diabetic Torii rat: an animal model of nonobese type 2 diabetes with severe diabetic complications. J Diabetes Res 2013:976209. https://doi.org/10.1155/2013/976209
Shinohara M, Masuyama T, Shoda T, Takahashi T, Katsuda Y, Komeda K et al (2000) A new spontaneously diabetic non-obese Torii rat strain with severe ocular complications. Int J Exp Diabetes Res 1(2):89–100
Fuse M, Yokoi N, Shinohara M, Masuyama T, Kitazawa R, Kitazawa S et al (2008) Identification of a major locus for islet inflammation and fibrosis in the spontaneously diabetic Torii rat. Physiol Genomics 35(1):96–105. https://doi.org/10.1152/physiolgenomics.90214.2008
Masuyama T, Fuse M, Yokoi N, Shinohara M, Tsujii H, Kanazawa M et al (2003) Genetic analysis for diabetes in a new rat model of nonobese type 2 diabetes, Spontaneously Diabetic Torii rat. Biochem Biophys Res Commun 304(1):196–206
Cheng ZJ, Vaskonen T, Tikkanen I, Nurminen K, Ruskoaho H, Vapaatalo H et al (2001) Endothelial dysfunction and salt-sensitive hypertension in spontaneously diabetic Goto-Kakizaki rats. Hypertension 37(2 Pt 2):433–439
Kaisaki PJ, Otto GW, Argoud K, Collins SC, Wallis RH, Wilder SP et al (2016) Transcriptome profiling in rat inbred strains and experimental cross reveals discrepant genetic architecture of genome-wide gene expression. G3 (Bethesda) 6(11):3671–3683. https://doi.org/10.1534/g3.116.033274
Dumas ME, Wilder SP, Bihoreau MT, Barton RH, Fearnside JF, Argoud K et al (2007) Direct quantitative trait locus mapping of mammalian metabolic phenotypes in diabetic and normoglycemic rat models. Nat Genet 39(5):666–672. https://doi.org/10.1038/ng2026
Portha B, Giroix MH, Tourrel-Cuzin C, Le-Stunff H, Movassat J (2012) The GK rat: a prototype for the study of non-overweight type 2 diabetes. Meth Mol Biol 933:125–159. https://doi.org/10.1007/978-1-62703-068-7_9
Nobrega MA, Woods LC, Fleming S, Jacob HJ (2009) Distinct genetic regulation of progression of diabetes and renal disease in the Goto-Kakizaki rat. Physiol Genomics 39(1):38–46. https://doi.org/10.1152/physiolgenomics.90389.2008
Cohen AM, Rosenmann E, Rosenthal T (1993) The Cohen diabetic (non-insulin-dependent) hypertensive rat model. Description of the model and pathologic findings. Am J Hypertens 6(12):989–995
Younis F, Leor J, Abassi Z, Landa N, Rath L, Hollander K et al (2018) Beneficial effect of the SGLT2 inhibitor empagliflozin on glucose homeostasis and cardiovascular parameters in the Cohen Rosenthal Diabetic Hypertensive (CRDH) rat. J Cardiovasc Pharmacol Ther 23(4):358–371. https://doi.org/10.1177/1074248418763808
Younis F, Stern N, Limor R, Oron Y, Zangen S, Rosenthal T (2010) Telmisartan ameliorates hyperglycemia and metabolic profile in nonobese Cohen-Rosenthal diabetic hypertensive rats via peroxisome proliferator activator receptor-gamma activation. Metabolism 59(8):1200–1209. https://doi.org/10.1016/j.metabol.2009.11.013
Rosenthal T, Erlich Y, Rosenmann E, Cohen A (1997) Effects of enalapril, losartan, and verapamil on blood pressure and glucose metabolism in the Cohen-Rosenthal diabetic hypertensive rat. Hypertension 29(6):1260–1264
Reaven GM, Twersky J, Chang H (1991) Abnormalities of carbohydrate and lipid metabolism in Dahl rats. Hypertension 18(5):630–635
Somova L, Channa ML (1999) Glucose metabolism and insulin sensitivity in Dahl hypertensive rats. Methods Find Exp Clin Pharmacol 21(6):421–425
Zicha J, Dobesova Z, Vokurkova M, Rauchova H, Hojna S, Kadlecova M et al (2012) Age-dependent salt hypertension in Dahl rats: fifty years of research. Physiol Res 61(Suppl 1):S35–S87
Donnelly R, Ho H, Reaven GM (1995) Effects of low sodium diet and unilateral nephrectomy on the development of carbohydrate-induced hypertension. Blood Press 4(3):164–169
Kotchen TA, Zhang HY, Covelli M, Blehschmidt N (1991) Insulin resistance and blood pressure in Dahl rats and in one-kidney, one-clip hypertensive rats. Am J Phys 261(6 Pt 1):E692–E697
Nagae A, Fujita M, Kawarazaki H, Matsui H, Ando K, Fujita T (2009) Effect of high fat loading in Dahl salt-sensitive rats. Clin Exp Hypertens 31(5):451–461
Zhang HY, Reddy S, Kotchen TA (1999) A high sucrose, high linoleic acid diet potentiates hypertension in the Dahl salt sensitive rat. Am J Hypertens 12(2 Pt 1):183–187
De Miguel C, Lund H, Mattson DL (2011) High dietary protein exacerbates hypertension and renal damage in Dahl SS rats by increasing infiltrating immune cells in the kidney. Hypertension 57(2):269–274. https://doi.org/10.1161/HYPERTENSIONAHA.110.154302
Mattson DL, Meister CJ, Marcelle ML (2005) Dietary protein source determines the degree of hypertension and renal disease in the Dahl salt-sensitive rat. Hypertension 45(4):736–741. https://doi.org/10.1161/01.HYP.0000153318.74544.cc
Levin BE, Dunn-Meynell AA, Balkan B, Keesey RE (1997) Selective breeding for diet-induced obesity and resistance in Sprague-Dawley rats. Am J Phys 273(2 Pt 2):R725–R730. https://doi.org/10.1152/ajpregu.1997.273.2.R725
Chang S, Graham B, Yakubu F, Lin D, Peters JC, Hill JO (1990) Metabolic differences between obesity-prone and obesity-resistant rats. Am J Phys 259(6 Pt 2):R1103–R1110. https://doi.org/10.1152/ajpregu.1990.259.6.R1103
Levin BE, Triscari J, Hogan S, Sullivan AC (1987) Resistance to diet-induced obesity: food intake, pancreatic sympathetic tone, and insulin. Am J Phys 252(3 Pt 2):R471–R478. https://doi.org/10.1152/ajpregu.1987.252.3.R471
Schemmel R, Mickelsen O, Gill JL (1970) Dietary obesity in rats: body weight and body fat accretion in seven strains of rats. J Nutr 100(9):1041–1048. https://doi.org/10.1093/jn/100.9.1041
Dobrian AD, Davies MJ, Prewitt RL, Lauterio TJ (2000) Development of hypertension in a rat model of diet-induced obesity. Hypertension 35(4):1009–1015
Giles ED, Jackman MR, MacLean PS (2016) Modeling diet-induced obesity with obesity-prone rats: implications for studies in females. Front Nutr 3:50. https://doi.org/10.3389/fnut.2016.00050
Panchal SK, Poudyal H, Iyer A, Nazer R, Alam A, Diwan V et al (2011) High-carbohydrate high-fat diet-induced metabolic syndrome and cardiovascular remodeling in rats. J Cardiovasc Pharmacol 57(1):51–64. https://doi.org/10.1097/FJC.0b013e3181feb90a
Moreno-Fernandez S, Garces-Rimon M, Vera G, Astier J, Landrier JF, Miguel M (2018) High fat/high glucose diet induces metabolic syndrome in an experimental rat model. Nutrients 10(10):E1502. https://doi.org/10.3390/nu10101502
Wong SK, Chin KY, Suhaimi FH, Fairus A, Ima-Nirwana S (2016) Animal models of metabolic syndrome: a review. Nutr Metab (Lond) 13:65. https://doi.org/10.1186/s12986-016-0123-9
Kwitek AE, Jacob HJ, Baker JE, Dwinell MR, Forster HV, Greene AS et al (2006) BN phenome: detailed characterization of the cardiovascular, renal, and pulmonary systems of the sequenced rat. Physiol Genomics 25(2):303–313. https://doi.org/10.1152/physiolgenomics.00288.2005
Brower M, Grace M, Kotz CM, Koya V (2015) Comparative analysis of growth characteristics of Sprague Dawley rats obtained from different sources. Lab Anim Res 31(4):166–173. https://doi.org/10.5625/lar.2015.31.4.166
Hansen C, Spuhler K (1984) Development of the National Institutes of Health genetically heterogeneous rat stock. Alcohol Clin Exp Res 8(5):477–479
Hermsen R, de Ligt J, Spee W, Blokzijl F, Schafer S, Adami E et al (2015) Genomic landscape of rat strain and substrain variation. BMC Genomics 16:357. https://doi.org/10.1186/s12864-015-1594-1
Baud A, Guryev V, Hummel O, Johannesson M, Rat Genome Sequencing and Mapping Consortium, Flint J (2014) Genomes and phenomes of a population of outbred rats and its progenitors. Sci Data 1:140011. https://doi.org/10.1038/sdata.2014.11
Woods LC, Mott R (2017) Heterogeneous stock populations for analysis of complex traits. Meth Mol Biol 1488:31–44. https://doi.org/10.1007/978-1-4939-6427-7_2
Alam I, Koller DL, Canete T, Blazquez G, Mont-Cardona C, Lopez-Aumatell R et al (2015) Fine mapping of bone structure and strength QTLs in heterogeneous stock rat. Bone 81:417–426. https://doi.org/10.1016/j.bone.2015.08.013
Holl K, He H, Wedemeyer M, Clopton L, Wert S, Meckes JK et al (2017) Heterogeneous stock rats: a model to study the genetics of despair-like behavior in adolescence. Genes Brain Behav 17(2):139–148. https://doi.org/10.1111/gbb.12410
Keele GR, Prokop JW, He H, Holl K, Littrell J, Deal A et al (2017) Genetic fine-mapping and identification of candidate genes and variants for adiposity traits in outbred rats. Obesity (Silver Spring) 26(1):213–222. https://doi.org/10.1002/oby.22075
Koch LG, Britton SL (2001) Artificial selection for intrinsic aerobic endurance running capacity in rats. Physiol Genomics 5(1):45–52. https://doi.org/10.1152/physiolgenomics.2001.5.1.45
Koch LG, Britton SL, Wisloff U (2012) A rat model system to study complex disease risks, fitness, aging, and longevity. Trends Cardiovasc Med 22(2):29–34. https://doi.org/10.1016/j.tcm.2012.06.007
Koch LG, Britton SL (2008) Development of animal models to test the fundamental basis of gene-environment interactions. Obesity (Silver Spring) 16(Suppl 3):S28–S32. https://doi.org/10.1038/oby.2008.513
Ren YY, Overmyer KA, Qi NR, Treutelaar MK, Heckenkamp L, Kalahar M et al (2013) Genetic analysis of a rat model of aerobic capacity and metabolic fitness. PLoS One 8(10):e77588. https://doi.org/10.1371/journal.pone.0077588
Zucker LM, Zucker TF (1961) FATTY, a new mutation in the rat. J Hered 52(6):275–278. https://doi.org/10.1093/oxfordjournals.jhered.a107093
Takaya K, Ogawa Y, Isse N, Okazaki T, Satoh N, Masuzaki H et al (1996) Molecular cloning of rat leptin receptor isoform complementary DNAs—identification of a missense mutation in Zucker fatty (fa/fa) rats. Biochem Biophys Res Commun 225(1):75–83. https://doi.org/10.1006/bbrc.1996.1133
White DW, Wang DW, Chua SC Jr, Morgenstern JP, Leibel RL, Baumann H et al (1997) Constitutive and impaired signaling of leptin receptors containing the Gln --> Pro extracellular domain fatty mutation. Proc Natl Acad Sci U S A 94(20):10657–10662
Peterson RG, Shaw WN, Neel M-A, Little LA, Eichberg J (1990) Zucker diabetic fatty rat as a model for non-insulin-dependent diabetes mellitus. ILAR J 32(3):16–19. https://doi.org/10.1093/ilar.32.3.16
Hattori T, Murase T, Ohtake M, Inoue T, Tsukamoto H, Takatsu M et al (2011) Characterization of a new animal model of metabolic syndrome: the DahlS.Z-Lepr(fa)/Lepr(fa) rat. Nutr Diabetes 1:e1. https://doi.org/10.1038/nutd.2010.1
Hiraoka-Yamamoto J, Nara Y, Yasui N, Onobayashi Y, Tsuchikura S, Ikeda K (2004) Establishment of a new animal model of metabolic syndrome: SHRSP fatty (fa/fa) rats. Clin Exp Pharmacol Physiol 31(1–2):107–109
Koletsky S (1973) Obese spontaneously hypertensive rats—a model for study of atherosclerosis. Exp Mol Pathol 19(1):53–60
Koletsky S (1975) Pathologic findings and laboratory data in a new strain of obese hypertensive rats. Am J Pathol 80(1):129–142
Takaya K, Ogawa Y, Hiraoka J, Hosoda K, Yamori Y, Nakao K et al (1996) Nonsense mutation of leptin receptor in the obese spontaneously hypertensive Koletsky rat. Nat Genet 14(2):130–131. https://doi.org/10.1038/ng1096-130
Moralejo DH, Hansen CT, Treuting P, Hessner MJ, Fuller JM, Van Yserloo B et al (2010) Differential effects of leptin receptor mutation on male and female BBDR Gimap5−/Gimap5− spontaneously diabetic rats. Physiol Genomics 41(1):9–20. https://doi.org/10.1152/physiolgenomics.00186.2009
Qi NR, Wang J, Zidek V, Landa V, Mlejnek P, Kazdova L et al (2005) A new transgenic rat model of hepatic steatosis and the metabolic syndrome. Hypertension 45(5):1004–1011
Pravenec M, Landa V, Zidek V, Musilova A, Kazdova L, Qi N et al (2003) Transgenic expression of CD36 in the spontaneously hypertensive rat is associated with amelioration of metabolic disturbances but has no effect on hypertension. Physiol Res 52(6):681–688
Herrera VL, Makrides SC, Xie HX, Adari H, Krauss RM, Ryan US et al (1999) Spontaneous combined hyperlipidemia, coronary heart disease and decreased survival in Dahl salt-sensitive hypertensive rats transgenic for human cholesteryl ester transfer protein. Nat Med 5(12):1383–1389. https://doi.org/10.1038/70956
Buehr M, Meek S, Blair K, Yang J, Ure J, Silva J et al (2008) Capture of authentic embryonic stem cells from rat blastocysts. Cell 135(7):1287–1298
Li P, Tong C, Mehrian-Shai R, Jia L, Wu N, Yan Y et al (2008) Germline competent embryonic stem cells derived from rat blastocysts. Cell 135(7):1299–1310
Tesson L, Usal C, Menoret S, Leung E, Niles BJ, Remy S et al (2011) Knockout rats generated by embryo microinjection of TALENs. Nat Biotechnol 29(8):695–696. https://doi.org/10.1038/nbt.1940
Geurts AM, Cost GJ, Freyvert Y, Zeitler B, Miller JC, Choi VM et al (2009) Knockout rats via embryo microinjection of zinc-finger nucleases. Science 325(5939):433. pii: 325/5939/433. https://doi.org/10.1126/science.1172447
Li W, Teng F, Li T, Zhou Q (2013) Simultaneous generation and germline transmission of multiple gene mutations in rat using CRISPR-Cas systems. Nat Biotechnol 31(8):684–686. https://doi.org/10.1038/nbt.2652
Meek S, Mashimo T, Burdon T (2017) From engineering to editing the rat genome. Mamm Genome 28(7):302–314. https://doi.org/10.1007/s00335-017-9705-8
Izumi R, Kusakabe T, Noguchi M, Iwakura H, Tanaka T, Miyazawa T et al (2018) CRISPR/Cas9-mediated Angptl8 knockout suppresses plasma triglyceride concentrations and adiposity in rats. J Lipid Res 59(9):1575–1585. https://doi.org/10.1194/jlr.M082099
Zallar LJ, Tunstall BJ, Richie CT, Zhang YJ, You ZB, Gardner EL et al (2019) Development and initial characterization of a novel ghrelin receptor CRISPR/Cas9 knockout wistar rat model. Int J Obes 43:344–354. https://doi.org/10.1038/s41366-018-0013-5
You P, Hu H, Chen Y, Zhao Y, Yang Y, Wang T et al (2016) Effects of melanocortin 3 and 4 receptor deficiency on energy homeostasis in rats. Sci Rep 6:34938. https://doi.org/10.1038/srep34938
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Kwitek, A.E. (2019). Rat Models of Metabolic Syndrome. In: Hayman, G., Smith, J., Dwinell, M., Shimoyama, M. (eds) Rat Genomics. Methods in Molecular Biology, vol 2018. Humana, New York, NY. https://doi.org/10.1007/978-1-4939-9581-3_13
Download citation
DOI: https://doi.org/10.1007/978-1-4939-9581-3_13
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-4939-9580-6
Online ISBN: 978-1-4939-9581-3
eBook Packages: Springer Protocols